These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 10213225

  • 1. Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.
    Ishikawa Y, Kubota T, Otani Y, Watanabe M, Teramoto T, Kumai K, Kitajima M, Takechi T, Okabe H, Fukushima M.
    Clin Cancer Res; 1999 Apr; 5(4):883-9. PubMed ID: 10213225
    [Abstract] [Full Text] [Related]

  • 2. Thymidylate synthetase and dihydropyrimidine dehydrogenase levels in gastric cancer.
    Ishikawa Y, Kubota T, Otani Y, Watanabe M, Teramoto T, Kumai K, Takechi T, Okabe H, Fukushima M, Kitajima M.
    Anticancer Res; 1999 Apr; 19(6C):5635-40. PubMed ID: 10697632
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of two fluorouracil administration regimens for colorectal cancer.
    Matsusaka S, Yamasaki H, Kitayama Y, Okada T, Maeda S.
    Oncol Rep; 2003 Apr; 10(1):109-13. PubMed ID: 12469154
    [Abstract] [Full Text] [Related]

  • 4. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in thymoma.
    Sasaki H, Fukai I, Kiriyama M, Kaji M, Yano M, Yamakawa Y, Fujii Y.
    Surg Today; 2003 Apr; 33(2):83-8. PubMed ID: 12616366
    [Abstract] [Full Text] [Related]

  • 5. Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil.
    Ishikawa Y, Kubota T, Otani Y, Watanabe M, Teramoto T, Kumai K, Takechi T, Okabe H, Fukushima M, Kitajima M.
    Jpn J Cancer Res; 2000 Jan; 91(1):105-12. PubMed ID: 10744051
    [Abstract] [Full Text] [Related]

  • 6. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.
    Terashima M, Irinoda T, Fujiwara H, Nakaya T, Takagane A, Abe K, Yonezawa H, Oyama K, Inaba T, Saito K, Takechi T, Fukushima M.
    Anticancer Res; 2002 Jan; 22(2A):761-8. PubMed ID: 12014648
    [Abstract] [Full Text] [Related]

  • 7. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
    Grem JL, Danenberg KD, Behan K, Parr A, Young L, Danenberg PV, Nguyen D, Drake J, Monks A, Allegra CJ.
    Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
    [Abstract] [Full Text] [Related]

  • 8. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M, Schwabe W, Sander S, Kron M, Sträter J, Polat S, Kettner E, Weiser HF, Baumann W, Schramm H, Häusler P, Ott K, Behnke D, Staib L, Beger HG, Link KH.
    Clin Cancer Res; 2003 Sep 15; 9(11):4116-24. PubMed ID: 14519634
    [Abstract] [Full Text] [Related]

  • 9. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K, Shiomi H, Mekata E, Kaizuka M, Endo Y, Kurumi Y, Tani T.
    Oncol Rep; 2006 Apr 15; 15(4):875-82. PubMed ID: 16525674
    [Abstract] [Full Text] [Related]

  • 10. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small-cell lung cancer.
    Shintani Y, Ohta M, Hirabayashi H, Tanaka H, Iuchi K, Nakagawa K, Maeda H, Kido T, Miyoshi S, Matsuda H.
    Lung Cancer; 2004 Aug 15; 45(2):189-96. PubMed ID: 15246190
    [Abstract] [Full Text] [Related]

  • 11. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
    Fukui Y, Oka T, Nagayama S, Danenberg PV, Danenberg KD, Fukushima M.
    Int J Mol Med; 2008 Dec 15; 22(6):709-16. PubMed ID: 19020767
    [Abstract] [Full Text] [Related]

  • 12. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
    Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB, Danenberg PV.
    Clin Cancer Res; 2000 Apr 15; 6(4):1322-7. PubMed ID: 10778957
    [Abstract] [Full Text] [Related]

  • 13. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
    Nita ME, Tominaga O, Nagawa H, Tsuruo T, Muto T.
    Hepatogastroenterology; 1998 Apr 15; 45(24):2117-22. PubMed ID: 9951876
    [Abstract] [Full Text] [Related]

  • 14. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer.
    Fakhrejahani E, Miyamoto A, Tanigawa N.
    Cancer Chemother Pharmacol; 2007 Aug 15; 60(3):437-46. PubMed ID: 17377791
    [Abstract] [Full Text] [Related]

  • 15. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
    Miyoshi T, Kondo K, Fujino H, Takahashi Y, Sawada N, Sakiyama S, Tsuyuguchi M, Kimura S, Sumitomo M, Monden Y.
    Anticancer Res; 2005 Aug 15; 25(2A):923-30. PubMed ID: 15868929
    [Abstract] [Full Text] [Related]

  • 16. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers.
    Baba H, Teramoto K, Kawamura T, Mori A, Imamura M, Arii S.
    Cancer Chemother Pharmacol; 2003 Dec 15; 52(6):469-76. PubMed ID: 13680162
    [Abstract] [Full Text] [Related]

  • 17. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
    Ichikawa W, Uetake H, Shirota Y, Yamada H, Nishi N, Nihei Z, Sugihara K, Hirayama R.
    Clin Cancer Res; 2003 Feb 15; 9(2):786-91. PubMed ID: 12576451
    [Abstract] [Full Text] [Related]

  • 18. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y, Harada K, Ferdous T, Yoshida H.
    Anticancer Res; 2007 Feb 15; 27(4B):2365-75. PubMed ID: 17695527
    [Abstract] [Full Text] [Related]

  • 19. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.
    Oncology; 2006 Feb 15; 70(5):366-77. PubMed ID: 17179731
    [Abstract] [Full Text] [Related]

  • 20. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test.
    Kakimoto M, Uetake H, Osanai T, Shirota Y, Takagi Y, Takeshita E, Toriya Y, Danenberg K, Danenberg PV, Sugihara K.
    Cancer Lett; 2005 Jun 01; 223(1):103-11. PubMed ID: 15890242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.